Psoriatic arthritis trials in Brazil
4 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.
- Phase 3Taking peopleA Study of Baricitinib in Participants From 1 Year to Less Than 18 Years Old With Juvenile Idiopathic Arthritis
- Where
- Botucatu, São Paulo
- Age
- 1 year to 18 years
- People
- 190 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT03773965 - Phase 3Taking peopleA Long-term Extension (LTE) Study of Guselkumab in Pediatric Participants
- Where
- Goiânia, Votuporanga
- Age
- 3 years to 64 years
- People
- 196 worldwide
- Run by
- Janssen Research & Development, LLC
See details and how to joinNCT06663332 · EU 2023-509560-16-00 - Phase 3Taking peopleA Study to Evaluate the Drug Levels, Efficacy, and Safety of Deucravacitinib (BMS-986165) in Pediatric Participants With Juvenile Psoriatic Arthritis
- Where
- Belo Horizonte, Cuiabá, Curitiba, Fortaleza, Porto Alegre, Recife, Rio de Janeiro, São Paulo, Vila Clementino, Xangri-lá
- Age
- 5 years to 17 years
- People
- 60 worldwide
- Run by
- Bristol-Myers Squibb
See details and how to joinNCT06869551 · EU 2024-517262-41-00 - Phase 4Taking peopleSafety and Immunogenicity of the Live Attenuated Tetravalent Butantan-Dengue Vaccine in Autoimmune Rheumatic Diseases
- Where
- São Paulo
- Age
- 12 years to 59 years
- People
- 477
- Run by
- University of Sao Paulo General Hospital
See details and how to joinNCT07087912